or Try an Advanced Search...

    ETF Components for LABD - Direxion Daily S&P Biotech Bear 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL F 0.78 1.91
    BMRN F -0.50 1.89
    BLUE F -0.29 1.87
    VRTX C 1.36 1.84
    SAGE F 4.06 1.80
    UTHR B -1.31 1.78
    REGN C 0.45 1.77
    AMGN B -0.22 1.75
    ALNY D -1.08 1.73
    EXAS F -7.84 1.73
    ABBV D -0.76 1.72
    ACAD F -2.19 1.68
    SRPT B -2.89 1.66
    BIIB C -0.11 1.65
    IONS F -1.89 1.64
    GILD F -0.74 1.64
    NBIX B -0.79 1.62
    BPMC A 0.41 1.61
    INCY D -0.24 1.51
    RARE F 1.10 1.49
    MRNA B 1.59 1.47
    LGND C 1.75 1.46
    ARWR F 0.85 1.45
    BHVN D 0.58 1.42
    PTCT C 0.19 1.40
    FOLD F 2.01 1.38
    AGIO B -3.64 1.37
    APLS F 2.34 1.24
    ALKS F 0.08 1.21
    MYGN A -0.47 1.08
    NTRA B 1.86 1.08
    IOVA D -2.44 1.07
    FGEN F 1.56 1.05
    RGNX F -0.27 1.05
    DCPH A 0.04 1.01
    CHRS F -4.98 0.99
    EBS C -3.64 0.96
    CDNA C 0.69 0.93
    HRTX C -0.86 0.84
    INSM D -6.78 0.81
    KPTI F -3.67 0.79
    ESPR D -5.33 0.79
    ALLK D 9.23 0.76
    IRWD F -1.82 0.75
    VCYT F -0.19 0.72
    HALO C -0.23 0.71
    FATE F 2.62 0.67
    EDIT F -3.43 0.66
    PBYI D 0.25 0.65
    MDGL D -2.24 0.59
    TGTX C -1.59 0.55
    ADVM F -2.94 0.55
    ALLO F -0.79 0.54
    CPRX D -0.31 0.53
    ANAB B -4.21 0.53
    XNCR B -0.63 0.49
    SGMO F -3.67 0.48
    ENTA D -0.41 0.47
    EGRX F 0.27 0.42
    GTHX B -3.08 0.42
    ATRA F -4.00 0.41
    VKTX B 1.92 0.38
    ANIK A -0.49 0.37
    VNDA B 6.52 0.35
    OPK D 6.25 0.35
    VCEL C 0.50 0.34
    TVTX F -2.84 0.33
    KOD D -1.29 0.29
    BBIO F 0.65 0.29
    NTLA F -0.16 0.29
    PGEN F 1.49 0.29
    DNLI D -0.26 0.28
    KRYS D -0.48 0.28
    GOSS F -2.65 0.27
    VYGR D 1.60 0.26
    MGNX D -1.73 0.25
    ALEC F -5.13 0.25
    CYTK D -1.39 0.25
    DVAX D -3.88 0.24
    YMAB C -1.45 0.24

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Chemical Compounds Inflammation Clinical Medicine Disease Immune System Immunology S&P 500 Cholesterol Genetics Infectious Diseases Monoclonal Antibody Nasdaq 100 Organ Systems
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Diagnostics & Research

    Recent News for Direxion Daily S&P Biotech Bear 3X Shares & its Holdings

    Date Stock Title
    May 27 REGN The Biggest Biotechnology Company in Europe
    May 26 MRNA Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
    May 26 VRTX Got $500? 3 Pharma Stocks to Buy and Hold Forever
    May 26 VRTX Is It Too Late to Buy Vertex Pharmaceuticals Stock?
    May 26 GILD Wall Street Breakfast: The Week Ahead
    May 26 AMGN Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
    May 26 MRNA Should You Buy This Stock After a Regulatory Setback?
    May 26 AMGN The Biggest Publicly Traded Biotech Company
    May 26 REGN The Biggest Publicly Traded Biotech Company
    May 25 AMGN Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
    May 25 ABBV Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
    May 25 MRNA Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
    May 25 VRTX 2 Biotech Stocks to Buy in May
    May 25 REGN 2 Biotech Stocks to Buy in May
    May 25 AMGN It's Unlikely That Amgen Inc.'s (NASDAQ:AMGN) CEO Will See A Huge Pay Rise This Year
    May 25 VRTX 3 High-Flying Stocks That Could Soar Even More
    May 25 MRNA Wall Street Breakfast: What Moved Markets
    May 25 ABBV Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
    May 25 VRTX Insider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
    May 25 PTCT Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
    The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Inverse ETF Bear Market ETF Repurchase Agreement Financial Regulation Forward Contract
    Back to the Main LABD Page...